Primary cutaneous zygomycosis in a burns patient: A review

Journal of Burn Care and Research

Volumn 29, Issue 2, 2008, Pages 286-290

  Ledgard, James Peter ^a   Van Hal, Sebastiaan ^b   Greenwood, John E ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; GENTAMICIN; POSACONAZOLE; VANCOMYCIN;

AMPUTATION; ANTIMICROBIAL THERAPY; BURN; BURN INFECTION; BURN PATIENT; CLINICAL FEATURE; DEBRIDEMENT; DERMATOMYCOSIS; DIAGNOSTIC PROCEDURE; HUMAN; HYPERBARIC OXYGEN; INFECTION RISK; MICROBIOLOGICAL EXAMINATION; MORTALITY; MUCORMYCOSIS; PATIENT CARE; PROGNOSIS; REVIEW; RISK FACTOR; SKIN BIOPSY; SKIN GRAFT; TREATMENT OUTCOME;

ADULT; BURNS; DEBRIDEMENT; HUMANS; MALE; RISK FACTORS; SKIN DISEASES; ZYGOMYCOSIS;

EID: 41849134354     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e31816673b1     Document Type: Review

References (37)

1. Ribes JA, Vanover-Sams CL, Baker DJ. Zyogmycetes in human disease. Clin Microbiol Rev 2000;13:236-301.
2. Kauffman CA. Zygomycosis: re-emergence of an old pathogen. Clin Infect Dis 2004;39:588-90.
3. Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis 2000;30:851-6.
4. Sugar AM. Agents of mucormycosis and related species. In: Mandell GI, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 5th ed. New York: Churchill Livingstone; 2000. p. 2685-95.
5. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005;41:634-53.
6. Cooter RD, Lim IS, Ellis DH, Leitch IOW. Burn wound zygomycosis caused by Apophysomyces elegans. J Clin Microbiol 1990;28:2151-3.
7. Greenberg RN, Scott LJ, Vaughn HH, Ribes JA. Zygomycosis (mucormycosis): emerging clinical importance and new treatments. Curr Opin Infect Dis 2004;17:517-25.
8. Tedder M, Spratt JA, Anstadt MP, et al. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg 1994;57:1044-50.
9. Kimura M, Smith MB, McGinnis MR. Zygomycosis due to Apophysomyces elegans: report of 2 cases and review of the literature. Arch Pathol Lab Med 1999;123:386-90.
10. Einsele H, Hebart H, Roller G, et al. Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol 1997;35:1353-60.
11. Blitzer A, Lawson W, Meyers BR, et al. Patient survival factors in paranasal sinus mucormycosis. Laryngoscope 1980;90:635-48.
12. Sun QN, Fothergill AW, McCarthy DI, et al. In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes. Antimicrob Agents Chemother 2002;46:1581-2.
13. Dannaoui E, Meletiadis J, Mouton JW, et al. In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 2003;51:45-52.
14. Dannaoui E, Meis JF, Loebenberg D, Verweij PE. Activity of posaconazole in treatment of experimental disseminated zygomycosis. Antimicrob Agents Chemother 2003;47:3647-50.
15. Dannaoui E, Afeltra J, Meis JF, Verweij PE. In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents. Antimicrob Agents Chemother 2002;46:2708-11.
16. Adam RD, Hunter G, DiTomasso J, Comerci G Jr. Mucormycosis: emerging prominence of cutaneous infections. Clin Infect Dis 1994;19:67-76.
17. Page R, Gardam DJ, Heath CH. Severe cutaneous mucormycosis (zygomycosis) due to Apophysomyces elegans (case report). ANZ J Surg 2001;71:184-6.
18. Bentur Y, Shupak A, Ramon Y, et al. Hyperbaric oxygen therapy for cutaneous/soft-tissue zygomycosis complicating diabetes mellitus. Plast Reconstr Surg 1998;102:822-824.
19. Chakrabarti A, Ghosh A, Prasad GS, et al. Apophysomyces elegans: an emerging zygomcete in India. J Clin Microbiol 2003;41:783-8.
20. Cloughley R, Kelehan J, Corbett-Feeney G, et al. Soft tissue infection with Absidia corymbifera in a patient with idiopathic aplastic anaemia. J Clin Microbiol 2002;40:725-7.
21. Bearer EA, Nelson PR, Chowers MY, Davis CE. Cutaneous zygomycosis caused by Saksenaea vasiformis. J Clin Microbiol 1994;32:1823-4.
22. Weitzman I, Della-Latta P, Housey G, Rebatta G. Mucor ramosissimus Samutsevitsch isolated from a thigh lesion. J Clin Microbiol 1993;31:2523-5.
23. Carter JE, Ulusarac O. Widespread cutaneous involvement by invasive Apophysomyces elegans in a gravid patient following trauma. Cutis 2003;72:221-4, 227-8.
24. Chakrabarti A, Kumar P, Padhye AA, et al. Primary cutaneous zygomycosis due to Saksenaea vasiformis and Apophysomyces elegans. Clin Infect Dis 1997;24:580-3.
25. Fingeroth JD, Roth RS, Talcott JA, Rinaldi MG. Zygomycosis due to Mucor circinelloides in a neutropenic patient receiving chemotherapy for acute myelogenous leukemia. Clin Infect Dis 1994;19:135-7.
26. Dickinson M, Kalayanamit T, Yang CA, Pomper GJ, Franco-Webb C, Rodman D. Cutaneous zygomycosis (mucormycosis) complicating endotracheal intubation. Chest 1998;114:340-2.
27. Prokopowicz GP, Bradley SF, Kauffman CA. Indolent zygomycosis associated with deferoxamine chelation therapy. Mycoses 1994;37:427-31.
28. Lopes JO, Pereira DV, Streher LA, Fenalte AA, Alves SH, Benevenga JP. Cutaneous zygomycosis caused by Absidia corymbifera in a leukemic patient. Mycopathologia 1995;130:89-92.
29. Sanchez MR, Ponge-Wilson I, Moy JA, Rosenthal S. Zygomycosis and HIV infection. J Am Acad Dermatol 1994;30:904-8.
30. Chandra S, Woodgyer A. Primary cutaneous zygomycosis due to Mucor circinelloides. Australas J Dermatol 2002;43:39-42.
31. Rubin AI, Grossman ME. Bull's-eye cutaneous infarct of zygomycosis: a bedside diagnosis confirmed by touch preparation. J Am Acad Dermatol 2004;51:996-1001.
32. Chaney S, Gopalan R, Berggren RE. Pulmonary Pseudallescheria boydii Infection with cutaneous zygomycosis after near drowning. South Med J 2004;97:683-7.
33. Koboyashi M, Hiruma M, Matsushita A, Kawai M, Ogawa H, Udagawa S. Cutaneous zygomycosis: a case report and review of Japanese reports. Mycoses 2001;44:311-15.
34. Quinio D, Karam A, Leroy JP, et al. Zygomycosis caused by Cunninghamella bertholletiae in a kidney transplant recipient. Med Mycol 2004;42:177-80.
35. Blair JE, Fredrikson LJ, Pockaj BA, Lucaire CS. Locally invasive cutaneous Apophysomyces elegans infection acquired from snapdragon patch test. Mayo Clin Proc 2002;77:717-20.
36. Kordy FN, Al-Mohsen IZ, Hashem FM, Almodovar E, Al Hajjar S, Walsh TJ. Successful treatment of a child with post-traumatic necrotizing fasciitis caused by Apophysomyces elegans: case report and review of literature. Pediatr Infect Dis J 2004;23:877-9.
37. Morales-Aguirre JJ, Agüero-Echeverría WM, Ornelas-Carsolio ME, Reséndiz-Sánchez J, Gómez-Barreto D, Cashat-Cruz M. Successful treatment of a primary cutaneous zygomycosis caused by Absidia corymbifera in a premature newborn. Pediatr Infect Dis J 2004;23:470-2.